Trails Edge Capital Partners, LP / FDMT
Trails Edge Capital Partners, LP’s 4d Molecular Therapeutics In Position
Does Trails Edge Capital Partners, LP own 4d Molecular Therapeutics In (FDMT)? Yes — 1.30M shares worth $12M (+2.78% of its 13F portfolio) as of Q1 2026.
Position Value
$12M
Q1 2026
Shares
1.30M
% of Portfolio
+2.78%
Quarters Held
1
currently held
Position History FDMT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.30M | $12M | +2.78% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of FDMT.